Prior studies have demonstrated that KOR-specific agonists exhibit antinociceptive effects and, unlike morphine and other opioid analgesics, KOR agonists do not result in respiratory depression or addictive effects (35). This evidence concerns the gene OPRK1 and respiratory depression.